Human immunodeficiency virus encephalitis

Archibald SL, Masliah E, Fennema-Notestine C, Marcotte TD, EUis RJ, McCutchan JA, Heaton RK, Grant I, Mallory M, Miller A, Jemigan TL (2004) Correlation of in vivo neuroimaging abnormalities with postmortem human immunodeficiency virus encephalitis and dendritic loss. Arch Neurol 61(3) 369-376... [Pg.21]

Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, Anderson C, Turchan J, Kolson D, Narayan O, Buch S (2004) Neuronal apoptosis is mediated by CXCLIO overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164(5) 1557-1566... [Pg.30]

Wiley CA, Achim C (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36(4) 673-676 Wiley CA, Baldwin M, Achim CL (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. Aids 10(8) 843-847... [Pg.31]

Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HS, Epstein L, Gelbard H, Elanagan E, Reinhard J, PirrucceUo SJ, Gendelman HE (1996) Human immunodeficiency virus encephalitis in SCID mice [see comments]. Am J Pathol 149 1027-1053. [Pg.310]

Tyor WR, Power C, Gendelman HE, Markham RB (1993) A model of human immunodeficiency virus encephalitis in scid mice. Proc Natl Acad Sci USA 90 8658-8662. [Pg.311]

D Aversa, T. G., Weidenheim, K. M., and Berman, J. W. (2002). CD40-CD40L interactions induce chemokine expression by human microglia Implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am. J. Pathol. 160, 559-567. [Pg.26]

Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999) Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155 1915-1927... [Pg.242]

Infections (encephalitis, neurosyphilis, sepsis, human immunodeficiency virus)... [Pg.770]

Potula R, Haorali J, Knipe B, Leibhai t J, Chrastil J, Heilman D, Dou H, Reddy R, Ghoipade A, Persidsky Y (2006) Alcohol abuse enhances neui oinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis. Am J Patliol 168 1335-1344. [Pg.310]

Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y (2002) Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci 22 2096-2105. [Pg.312]

Dou H, Birusingh K, Farad J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendehnan HE (2003) Neuropro-tective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23 9162-9170. [Pg.308]

Brugieres P, Combes C, Ricolfi F, Houhou S, Sadik JC, Thomas P, Gray F, Gaston A (1995) [Imagery of human immunodeficiency virus (HIV) encephalitis]. J Neuroradiol 22 163-168. [Pg.761]

Ribera E, Fernandez-Sola A, Juste C, Rovira A, Romero FJ, Armadans-Gil L, Ruiz I, Ocana I, Pahissa A. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients. Clin Infect Dis 1999 29(6) 1461-6. [Pg.3050]

Opravil, M. et al., Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as a combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasma encephalitis in human immunodeficiency virus-infected patients, Clin. Infect. Dis., 20, 531, 1995. [Pg.23]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...